Headlands Technologies’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436K | Buy |
11,983
+10,360
| +638% | +$377K | 0.05% | 335 |
|
|
2025
Q1 | $58.8K | Buy |
+1,623
| New | +$58.8K | 0.01% | 679 |
|
|
2024
Q4 | – | Sell |
-12,052
| Closed | -$669K | – | 1511 |
|
|
2024
Q3 | $669K | Buy |
12,052
+5,928
| +97% | +$329K | 0.08% | 282 |
|
|
2024
Q2 | $252K | Buy |
6,124
+5,530
| +931% | +$227K | 0.03% | 418 |
|
|
2024
Q1 | $27.7K | Buy |
+594
| New | +$27.7K | 0.01% | 843 |
|
|
2023
Q4 | – | Sell |
-3,351
| Closed | -$119K | – | 1236 |
|
|
2023
Q3 | $119K | Buy |
3,351
+1,127
| +51% | +$40.2K | 0.06% | 269 |
|
|
2023
Q2 | $103K | Buy |
2,224
+2,186
| +5,753% | +$101K | 0.03% | 382 |
|
|
2023
Q1 | $1.52K | Buy |
+38
| New | +$1.52K | ﹤0.01% | 441 |
|